Literature DB >> 33447574

Pancreatic neuroendocrine tumours: spectrum of imaging findings.

Eleonora Bicci1, Diletta Cozzi1, Riccardo Ferrari2, Giulia Grazzini1, Silvia Pradella1, Vittorio Miele1.   

Abstract

Pancreatic neuroendocrine tumours (pNETs) are rare and heterogeneous group of neoplasms presenting with a wide variety of symptoms and biological behaviour, from indolent to aggressive ones. pNETs are stratified into functional or non-functional, because of their ability to produce metabolically active hormones. pNETs can be an isolate phenomenon or a part of a hereditary syndrome like von Hippel-Lindau syndrome or neurofibromatosis-1. The incidence has increased in the last years, also because of the improvement of cross-sectional imaging. Computed tomography (CT), magnetic resonance imaging (MRI) and functional imaging are the mainstay imaging modalities used for tumour detection and disease extension assessment, due to easy availability and better contrast/spatial resolution. Radiological imaging plays a fundamental role in detection, characterization and surveillance of pNETs and is involved in almost every stage of patients' management. Moreover, with specific indications and techniques, interventional radiology can also play a role in therapeutic management. Surgery is the treatment of choice, consisting of either partial pancreatectomy or enucleation of the primary tumour. This article reviews the radiologic features of different pNETs as well as imaging mimics, in order to help radiologists to avoid potential pitfalls, to reach the correct diagnosis and to support the multidisciplinary team in establishing the right treatment. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Neuroendocrine tumour (NET); computed tomography (CT); magnetic resonance; radiomics

Year:  2020        PMID: 33447574      PMCID: PMC7804535          DOI: 10.21037/gs-20-537

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  3 in total

1.  [ELF4 promotes proliferation and inhibits apoptosis of human insulinoma cells by activating Akt signaling].

Authors:  G Wei; L Wang; X Wan; Y Tan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-08-31

2.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 3.  Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.

Authors:  Ginevra Danti; Federica Flammia; Benedetta Matteuzzi; Diletta Cozzi; Valentina Berti; Giulia Grazzini; Silvia Pradella; Laura Recchia; Luca Brunese; Vittorio Miele
Journal:  Radiol Med       Date:  2021-08-24       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.